Summary

Definition and Scope:
The osteoarthritis pain drugs market encompasses pharmaceutical products designed to alleviate pain and inflammation associated with osteoarthritis, a degenerative joint disease characterized by cartilage breakdown. These drugs include nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics (e.g., acetaminophen), corticosteroids, hyaluronic acid injections, and disease-modifying osteoarthritis drugs (DMOADs). The market is driven by the rising prevalence of osteoarthritis, particularly among aging populations, increased obesity rates, and sedentary lifestyles. Additionally, advancements in biologics and regenerative therapies, such as stem cell treatments, are expanding treatment options. However, challenges like side effects from long-term NSAID use, high costs of biologics, and limited efficacy of existing treatments restrain growth. The market is highly competitive, with key players focusing on R&D for novel therapies and expanding into emerging markets with unmet medical needs. Regulatory approvals and reimbursement policies significantly influence market dynamics.
This report offers a comprehensive analysis of the global Osteoarthritis Pain Drugs market, examining all key dimensions. It provides both a macro-level overview and micro-level market details, including market size, trends, competitive landscape, niche segments, growth drivers, and key challenges.

The global Osteoarthritis Pain Drugs market size was estimated at USD 10939.13 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.76% during the forecast period.

Report Framework and Key Highlights:
Market Dynamics: Identification of major market drivers, restraints, opportunities, and challenges.
Trend Analysis: Examination of ongoing and emerging trends impacting the market.
Competitive Landscape: Detailed profiles and market positioning of major players, including market share, operational status, product offerings, and strategic developments.
Strategic Analysis Tools: SWOT Analysis, Porter’s Five Forces Analysis, PEST Analysis, Value Chain Analysis
Market Segmentation: By type, application, region, and end-user industry.
Forecasting and Growth Projections: In-depth revenue forecasts and CAGR analysis through 2033.
This report equips readers with critical insights to navigate competitive dynamics and develop effective strategies. Whether assessing a new market entry or refining existing strategies, the report serves as a valuable tool for:
Industry players
Investors
Researchers
Consultants
Business strategists
And all stakeholders with an interest or investment in the Osteoarthritis Pain Drugs market.

Global Osteoarthritis Pain Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Companies Profiled
Pfizer
Bayer
SK Chemicals
GSK
Sanofi
Crystal Genomics
Johnson and Johnson
Sino Biopharmaceutical
Haohai Biological
Zhejiang Chengyi Pharmaceutical
Freda
Bright Future
Jingfeng Pharmaceutical
Chugai Pharmaceutical
Mikasa Seiyaku
Taisho Pharmaceutical
Seikagaku Corporation
GlaxoSmithKline
Eli Lilly
Novartis
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical

Market Segmentation by Type
Oral
Injection
External

Market Segmentation by Application
Medical Care
Personal Care

Geographic Segmentation
North America: United States, Canada, Mexico
Europe: Germany, France, Italy, U.K., Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium, Russia.
Asia-Pacific: China, Japan, South Korea, India, Australia, Indonesia, Malaysia, Philippines, Singapore, Thailand
South America: Brazil, Argentina, Colombia.
Middle East and Africa (MEA): Saudi Arabia, United Arab Emirates, Egypt, Nigeria, South Africa, Rest of MEA

Report Framework and Chapter Summary
Chapter 1: Report Scope and Market Definition
This chapter outlines the statistical boundaries and scope of the report. It defines the segmentation standards used throughout the study, including criteria for dividing the market by region, product type, application, and other relevant dimensions. It establishes the foundational definitions and classifications that guide the rest of the analysis.
Chapter 2: Executive Summary
This chapter presents a concise summary of the market’s current status and future outlook across different segments—by geography, product type, and application. It includes key metrics such as market size, growth trends, and development potential for each segment. The chapter offers a high-level overview of the Osteoarthritis Pain Drugs Market, highlighting its evolution over the short, medium, and long term.
Chapter 3: Competitive Landscape
This chapter provides a detailed assessment of the market's competitive environment. It covers market share, production capacity, output, pricing trends, and strategic developments such as mergers, acquisitions, and expansion plans of leading players. This analysis offers a comprehensive view of the positioning and performance of top competitors.
Chapter 4: Industry Chain and Value Chain Analysis
This chapter explores the full industry chain, from upstream raw material suppliers to downstream application sectors. It includes a value chain analysis that highlights the interconnections and dependencies across various parts of the ecosystem.
Chapter 5: Market Dynamics and Policy Environment
This chapter explores the latest developments in the market, identifying key growth drivers, restraints, challenges, and risks faced by industry participants. It also includes an analysis of the policy and regulatory landscape affecting the market, providing insight into how external factors may shape future performance.
Chapter 6: Market Segmentation by Product Type
This chapter examines the market based on product type, analyzing the size, growth trends, and potential of each segment. It helps stakeholders identify underexplored or high-potential product categories—often referred to as “blue ocean” opportunities.
Chapter 7: Market Segmentation by Application
This chapter analyzes the market based on application fields, providing insights into the scale and future development of each application segment. It supports readers in identifying high-growth areas across downstream markets.
Chapters 8: Regional Market Analysis by Consumption
These chapters offer in-depth, quantitative evaluations of market size and growth potential across major regions and countries. Each chapter assesses regional consumption patterns, market dynamics, development prospects, and available capacity. The analysis helps readers understand geographical differences and opportunities in global markets.
Chapter 9: Regional Market Analysis by Production
These chapters shares the main producing countries of Osteoarthritis Pain Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10: Company Profiles
This chapter presents comprehensive profiles of leading companies operating in the market. For each company, it details sales revenue, volume, pricing, gross profit margin, market share, product offerings, and recent strategic developments. This section offers valuable insight into corporate performance and strategy.
Chapter 12: Key Findings and Conclusions
The final chapter summarizes the main takeaways from the report, presenting the core conclusions, strategic recommendations, and implications for stakeholders. It encapsulates the insights drawn from all previous chapters.

ページTOPに戻る

Table of Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Osteoarthritis Pain Drugs
1.2 Key Market Segments
1.2.1 Osteoarthritis Pain Drugs Segment by Type
1.2.2 Osteoarthritis Pain Drugs Segment by Application
1.3 Methodology & Sources of Information

2

3 Global Osteoarthritis Pain Drugs Market Overview
3.1 Global Osteoarthritis Pain Drugs Market Overview
3.1.1 Global Osteoarthritis Pain Drugs Market Size and Forecasts (2020-2035)
3.1.2 Global Osteoarthritis Pain Drugs Market: Capacity and Utilization Outlook (2020–2035)
3.2 Market Segment Executive Summary
3.3 Global Market Size by Region

4 Osteoarthritis Pain Drugs Market Competitive Landscape
4.1 Company Assessment Quadrant
4.2 Global Osteoarthritis Pain Drugs Product Life Cycle
4.3 Global Osteoarthritis Pain Drugs Sales by Manufacturers (2020-2025)
4.4 Global Osteoarthritis Pain Drugs Revenue Market Share by Manufacturers (2020-2025)
4.5 Osteoarthritis Pain Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Osteoarthritis Pain Drugs Average Price by Manufacturers (2020-2025)
4.7 Production Capacity and Capacity Utilization Rate of Major Osteoarthritis Pain Drugs Manufacturers
4.8 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
4.9 Osteoarthritis Pain Drugs Market Competitive Situation and Trends
4.9.1 Osteoarthritis Pain Drugs Market Concentration Rate
4.9.2 Global 5 and 10 Largest Osteoarthritis Pain Drugs Players Market Share by Revenue
4.9.3 Mergers & Acquisitions, Expansion

5 Osteoarthritis Pain Drugs Industry Chain Analysis
5.1 Osteoarthritis Pain Drugs Industry Chain Analysis
5.2 Market Overview of Key Raw Materials
5.3 Midstream Market Analysis
5.4 Downstream Customer Analysis

6 The Development and Dynamics of Osteoarthritis Pain Drugs Market
6.1 Key Development Trends
6.2 Driving Factors
6.3 Market Challenges
6.4 Industry News
6.4.1 New Product Developments
6.4.2 Mergers & Acquisitions
6.4.3 Expansions
6.4.4 Collaboration/Supply Contracts
6.5 PEST Analysis
6.5.1 Political Environment Analysis
6.5.2 Economic Environment Analysis
6.5.3 Social Environment Analysis
6.5.4 Technological Environment Analysis
6.6 Global Osteoarthritis Pain Drugs Market Porter's Five Forces Analysis
6.6.1 Global Trade Frictions
6.6.2 U.S. Tariff Policy
6.6.3 Global Trade Frictions and Their Impacts on Osteoarthritis Pain Drugs Market

7 Osteoarthritis Pain Drugs Market Segmentation by Type
7.1 Evaluation Matrix of Segment Market Development Potential (Type)
7.2 Global Osteoarthritis Pain Drugs Sales Market Share by Type (2020-2025)
7.3 Global Osteoarthritis Pain Drugs Market Size by Type (2020-2025)
7.4 Global Osteoarthritis Pain Drugs Price by Type (2020-2025)

8 Osteoarthritis Pain Drugs Market Segmentation by Application
8.1 Evaluation Matrix of Segment Market Development Potential (Application)
8.2 Global Osteoarthritis Pain Drugs Market Sales by Application (2020-2025)
8.3 Global Osteoarthritis Pain Drugs Market Size (M USD) by Application (2020-2025)
8.4 Global Osteoarthritis Pain Drugs Sales Growth Rate by Application (2020-2025)

9 Osteoarthritis Pain Drugs Market Segmentation by Region
9.1 Global Osteoarthritis Pain Drugs Sales by Region
9.1.1 Global Osteoarthritis Pain Drugs Sales by Region
9.1.2 Global Osteoarthritis Pain Drugs Sales Market Share by Region
9.2 Global Osteoarthritis Pain Drugs Market Size by Region
9.2.1 Global Osteoarthritis Pain Drugs Market Size by Region
9.2.2 Global Osteoarthritis Pain Drugs Market Size by Region
9.3 North America
9.3.1 North America Osteoarthritis Pain Drugs Sales by Country
9.3.2 North America Osteoarthritis Pain Drugs Market Size by Country
9.3.3 U.S. Market Overview
9.3.4 Canada Market Overview
9.3.5 Mexico Market Overview
9.4 Europe
9.4.1 Europe Osteoarthritis Pain Drugs Sales by Country
9.4.2 Europe Osteoarthritis Pain Drugs Market Size by Country
9.4.3 Germany Market Overview
9.4.4 France Market Overview
9.4.5 U.K. Market Overview
9.4.6 Italy Market Overview
9.4.7 Spain Market Overview
9.5 Asia Pacific
9.5.1 Asia Pacific Osteoarthritis Pain Drugs Sales by Region
9.5.2 Asia Pacific Osteoarthritis Pain Drugs Market Size by Region
9.5.3 China Market Overview
9.5.4 Japan Market Overview
9.5.5 South Korea Market Overview
9.5.6 India Market Overview
9.5.7 Southeast Asia Market Overview
9.6 South America
9.6.1 South America Osteoarthritis Pain Drugs Sales by Country
9.6.2 South America Osteoarthritis Pain Drugs Market Size by Country
9.6.3 Brazil Market Overview
9.6.4 Argentina Market Overview
9.6.5 Columbia Market Overview
9.7 Middle East and Africa
9.7.1 Middle East and Africa Osteoarthritis Pain Drugs Sales by Region
9.7.2 Middle East and Africa Osteoarthritis Pain Drugs Market Size by Region
9.7.3 Saudi Arabia Market Overview
9.7.4 UAE Market Overview
9.7.5 Egypt Market Overview
9.7.6 Nigeria Market Overview
9.7.7 South Africa Market Overview

10 Osteoarthritis Pain Drugs Market Production by Region
10.1 Global Production of Osteoarthritis Pain Drugs by Region(2020-2025)
10.2 Global Osteoarthritis Pain Drugs Revenue Market Share by Region (2020-2025)
10.3 Global Osteoarthritis Pain Drugs Production, Revenue, Price and Gross Margin (2020-2025)
10.4 North America Osteoarthritis Pain Drugs Production
10.4.1 North America Osteoarthritis Pain Drugs Production Growth Rate (2020-2025)
10.4.2 North America Osteoarthritis Pain Drugs Production, Revenue, Price and Gross Margin (2020-2025)
10.5 Europe Osteoarthritis Pain Drugs Production
10.5.1 Europe Osteoarthritis Pain Drugs Production Growth Rate (2020-2025)
10.5.2 Europe Osteoarthritis Pain Drugs Production, Revenue, Price and Gross Margin (2020-2025)
10.6 Japan Osteoarthritis Pain Drugs Production (2020-2025)
10.6.1 Japan Osteoarthritis Pain Drugs Production Growth Rate (2020-2025)
10.6.2 Japan Osteoarthritis Pain Drugs Production, Revenue, Price and Gross Margin (2020-2025)
10.7 China Osteoarthritis Pain Drugs Production (2020-2025)
10.7.1 China Osteoarthritis Pain Drugs Production Growth Rate (2020-2025)
10.7.2 China Osteoarthritis Pain Drugs Production, Revenue, Price and Gross Margin (2020-2025)

11 Key Companies Profile
11.1 Pfizer
11.1.1 Pfizer Basic Information
11.1.2 Pfizer Osteoarthritis Pain Drugs Product Overview
11.1.3 Pfizer Osteoarthritis Pain Drugs Product Market Performance
11.1.4 Pfizer Business Overview
11.1.5 Pfizer SWOT Analysis
11.1.6 Pfizer Recent Developments
11.2 Bayer
11.2.1 Bayer Basic Information
11.2.2 Bayer Osteoarthritis Pain Drugs Product Overview
11.2.3 Bayer Osteoarthritis Pain Drugs Product Market Performance
11.2.4 Bayer Business Overview
11.2.5 Bayer SWOT Analysis
11.2.6 Bayer Recent Developments
11.3 SK Chemicals
11.3.1 SK Chemicals Basic Information
11.3.2 SK Chemicals Osteoarthritis Pain Drugs Product Overview
11.3.3 SK Chemicals Osteoarthritis Pain Drugs Product Market Performance
11.3.4 SK Chemicals Business Overview
11.3.5 SK Chemicals SWOT Analysis
11.3.6 SK Chemicals Recent Developments
11.4 GSK
11.4.1 GSK Basic Information
11.4.2 GSK Osteoarthritis Pain Drugs Product Overview
11.4.3 GSK Osteoarthritis Pain Drugs Product Market Performance
11.4.4 GSK Business Overview
11.4.5 GSK Recent Developments
11.5 Sanofi
11.5.1 Sanofi Basic Information
11.5.2 Sanofi Osteoarthritis Pain Drugs Product Overview
11.5.3 Sanofi Osteoarthritis Pain Drugs Product Market Performance
11.5.4 Sanofi Business Overview
11.5.5 Sanofi Recent Developments
11.6 Crystal Genomics
11.6.1 Crystal Genomics Basic Information
11.6.2 Crystal Genomics Osteoarthritis Pain Drugs Product Overview
11.6.3 Crystal Genomics Osteoarthritis Pain Drugs Product Market Performance
11.6.4 Crystal Genomics Business Overview
11.6.5 Crystal Genomics Recent Developments
11.7 Johnson and Johnson
11.7.1 Johnson and Johnson Basic Information
11.7.2 Johnson and Johnson Osteoarthritis Pain Drugs Product Overview
11.7.3 Johnson and Johnson Osteoarthritis Pain Drugs Product Market Performance
11.7.4 Johnson and Johnson Business Overview
11.7.5 Johnson and Johnson Recent Developments
11.8 Sino Biopharmaceutical
11.8.1 Sino Biopharmaceutical Basic Information
11.8.2 Sino Biopharmaceutical Osteoarthritis Pain Drugs Product Overview
11.8.3 Sino Biopharmaceutical Osteoarthritis Pain Drugs Product Market Performance
11.8.4 Sino Biopharmaceutical Business Overview
11.8.5 Sino Biopharmaceutical Recent Developments
11.9 Haohai Biological
11.9.1 Haohai Biological Basic Information
11.9.2 Haohai Biological Osteoarthritis Pain Drugs Product Overview
11.9.3 Haohai Biological Osteoarthritis Pain Drugs Product Market Performance
11.9.4 Haohai Biological Business Overview
11.9.5 Haohai Biological Recent Developments
11.10 Zhejiang Chengyi Pharmaceutical
11.10.1 Zhejiang Chengyi Pharmaceutical Basic Information
11.10.2 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product Overview
11.10.3 Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product Market Performance
11.10.4 Zhejiang Chengyi Pharmaceutical Business Overview
11.10.5 Zhejiang Chengyi Pharmaceutical Recent Developments
11.11 Freda
11.11.1 Freda Basic Information
11.11.2 Freda Osteoarthritis Pain Drugs Product Overview
11.11.3 Freda Osteoarthritis Pain Drugs Product Market Performance
11.11.4 Freda Business Overview
11.11.5 Freda Recent Developments
11.12 Bright Future
11.12.1 Bright Future Basic Information
11.12.2 Bright Future Osteoarthritis Pain Drugs Product Overview
11.12.3 Bright Future Osteoarthritis Pain Drugs Product Market Performance
11.12.4 Bright Future Business Overview
11.12.5 Bright Future Recent Developments
11.13 Jingfeng Pharmaceutical
11.13.1 Jingfeng Pharmaceutical Basic Information
11.13.2 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Product Overview
11.13.3 Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Product Market Performance
11.13.4 Jingfeng Pharmaceutical Business Overview
11.13.5 Jingfeng Pharmaceutical Recent Developments
11.14 Chugai Pharmaceutical
11.14.1 Chugai Pharmaceutical Basic Information
11.14.2 Chugai Pharmaceutical Osteoarthritis Pain Drugs Product Overview
11.14.3 Chugai Pharmaceutical Osteoarthritis Pain Drugs Product Market Performance
11.14.4 Chugai Pharmaceutical Business Overview
11.14.5 Chugai Pharmaceutical Recent Developments
11.15 Mikasa Seiyaku
11.15.1 Mikasa Seiyaku Basic Information
11.15.2 Mikasa Seiyaku Osteoarthritis Pain Drugs Product Overview
11.15.3 Mikasa Seiyaku Osteoarthritis Pain Drugs Product Market Performance
11.15.4 Mikasa Seiyaku Business Overview
11.15.5 Mikasa Seiyaku Recent Developments
11.16 Taisho Pharmaceutical
11.16.1 Taisho Pharmaceutical Basic Information
11.16.2 Taisho Pharmaceutical Osteoarthritis Pain Drugs Product Overview
11.16.3 Taisho Pharmaceutical Osteoarthritis Pain Drugs Product Market Performance
11.16.4 Taisho Pharmaceutical Business Overview
11.16.5 Taisho Pharmaceutical Recent Developments
11.17 Seikagaku Corporation
11.17.1 Seikagaku Corporation Basic Information
11.17.2 Seikagaku Corporation Osteoarthritis Pain Drugs Product Overview
11.17.3 Seikagaku Corporation Osteoarthritis Pain Drugs Product Market Performance
11.17.4 Seikagaku Corporation Business Overview
11.17.5 Seikagaku Corporation Recent Developments
11.18 GlaxoSmithKline
11.18.1 GlaxoSmithKline Basic Information
11.18.2 GlaxoSmithKline Osteoarthritis Pain Drugs Product Overview
11.18.3 GlaxoSmithKline Osteoarthritis Pain Drugs Product Market Performance
11.18.4 GlaxoSmithKline Business Overview
11.18.5 GlaxoSmithKline Recent Developments
11.19 Eli Lilly
11.19.1 Eli Lilly Basic Information
11.19.2 Eli Lilly Osteoarthritis Pain Drugs Product Overview
11.19.3 Eli Lilly Osteoarthritis Pain Drugs Product Market Performance
11.19.4 Eli Lilly Business Overview
11.19.5 Eli Lilly Recent Developments
11.20 Novartis
11.20.1 Novartis Basic Information
11.20.2 Novartis Osteoarthritis Pain Drugs Product Overview
11.20.3 Novartis Osteoarthritis Pain Drugs Product Market Performance
11.20.4 Novartis Business Overview
11.20.5 Novartis Recent Developments
11.21 Horizon Pharma
11.21.1 Horizon Pharma Basic Information
11.21.2 Horizon Pharma Osteoarthritis Pain Drugs Product Overview
11.21.3 Horizon Pharma Osteoarthritis Pain Drugs Product Market Performance
11.21.4 Horizon Pharma Business Overview
11.21.5 Horizon Pharma Recent Developments
11.22 Abbott
11.22.1 Abbott Basic Information
11.22.2 Abbott Osteoarthritis Pain Drugs Product Overview
11.22.3 Abbott Osteoarthritis Pain Drugs Product Market Performance
11.22.4 Abbott Business Overview
11.22.5 Abbott Recent Developments
11.23 Mylan
11.23.1 Mylan Basic Information
11.23.2 Mylan Osteoarthritis Pain Drugs Product Overview
11.23.3 Mylan Osteoarthritis Pain Drugs Product Market Performance
11.23.4 Mylan Business Overview
11.23.5 Mylan Recent Developments
11.24 Daiichi Sankyo
11.24.1 Daiichi Sankyo Basic Information
11.24.2 Daiichi Sankyo Osteoarthritis Pain Drugs Product Overview
11.24.3 Daiichi Sankyo Osteoarthritis Pain Drugs Product Market Performance
11.24.4 Daiichi Sankyo Business Overview
11.24.5 Daiichi Sankyo Recent Developments
11.25 TEVA
11.25.1 TEVA Basic Information
11.25.2 TEVA Osteoarthritis Pain Drugs Product Overview
11.25.3 TEVA Osteoarthritis Pain Drugs Product Market Performance
11.25.4 TEVA Business Overview
11.25.5 TEVA Recent Developments
11.26 Almatica Pharma
11.26.1 Almatica Pharma Basic Information
11.26.2 Almatica Pharma Osteoarthritis Pain Drugs Product Overview
11.26.3 Almatica Pharma Osteoarthritis Pain Drugs Product Market Performance
11.26.4 Almatica Pharma Business Overview
11.26.5 Almatica Pharma Recent Developments
11.27 Astellas Pharma
11.27.1 Astellas Pharma Basic Information
11.27.2 Astellas Pharma Osteoarthritis Pain Drugs Product Overview
11.27.3 Astellas Pharma Osteoarthritis Pain Drugs Product Market Performance
11.27.4 Astellas Pharma Business Overview
11.27.5 Astellas Pharma Recent Developments
11.28 Tide Pharmaceutical
11.28.1 Tide Pharmaceutical Basic Information
11.28.2 Tide Pharmaceutical Osteoarthritis Pain Drugs Product Overview
11.28.3 Tide Pharmaceutical Osteoarthritis Pain Drugs Product Market Performance
11.28.4 Tide Pharmaceutical Business Overview
11.28.5 Tide Pharmaceutical Recent Developments
11.29 Iroko Pharmaceuticals
11.29.1 Iroko Pharmaceuticals Basic Information
11.29.2 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product Overview
11.29.3 Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product Market Performance
11.29.4 Iroko Pharmaceuticals Business Overview
11.29.5 Iroko Pharmaceuticals Recent Developments
11.30 Hengrui Pharmaceutical
11.30.1 Hengrui Pharmaceutical Basic Information
11.30.2 Hengrui Pharmaceutical Osteoarthritis Pain Drugs Product Overview
11.30.3 Hengrui Pharmaceutical Osteoarthritis Pain Drugs Product Market Performance
11.30.4 Hengrui Pharmaceutical Business Overview
11.30.5 Hengrui Pharmaceutical Recent Developments

12 Osteoarthritis Pain Drugs Market Forecast by Region
12.1 Global Osteoarthritis Pain Drugs Market Size Forecast
12.2 Global Osteoarthritis Pain Drugs Market Forecast by Region
12.2.1 North America Market Size Forecast by Country
12.2.2 Europe Osteoarthritis Pain Drugs Market Size Forecast by Country
12.2.3 Asia Pacific Osteoarthritis Pain Drugs Market Size Forecast by Region
12.2.4 South America Osteoarthritis Pain Drugs Market Size Forecast by Country
12.2.5 Middle East and Africa Osteoarthritis Pain Drugs Market Size Forecast by Country

13 Forecast Market by Type and by Application (2026-2035)
13.1 Global Osteoarthritis Pain Drugs Market Forecast by Type (2026-2035)
13.1.1 Global Forecasted Sales of Osteoarthritis Pain Drugs by Type (2026-2035)
13.1.2 Global Osteoarthritis Pain Drugs Market Size Forecast by Type (2026-2035)
13.1.3 Global Forecasted Price of Osteoarthritis Pain Drugs by Type (2026-2035)
13.2 Global Osteoarthritis Pain Drugs Market Forecast by Application (2026-2035)
13.2.1 Global Osteoarthritis Pain Drugs Sales (K MT) Forecast by Application
13.2.2 Global Osteoarthritis Pain Drugs Market Size (M USD) Forecast by Application (2026-2035)

14 Conclusion and Key Findings

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Osteoarthritis Pain Drugs Market Size by Type (M USD)
Table 4. Global Osteoarthritis Pain Drugs Market Size by Application
Table 5. Osteoarthritis Pain Drugs Market Size Comparison by Region (M USD)
Table 6. Osteoarthritis Pain Drugs Market Size by Country (M USD)
Table 7. Global Osteoarthritis Pain Drugs Sales (K MT) by Manufacturers (2020-2025)
Table 8. Global Osteoarthritis Pain Drugs Sales Market Share by Manufacturers (2020-2025)
Table 9. Global Osteoarthritis Pain Drugs Revenue (M USD) by Manufacturers (2020-2025)
Table 10. Global Osteoarthritis Pain Drugs Revenue Share by Manufacturers (2020-2025)
Table 11. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Pain Drugs as of 2025)
Table 12. Global Market Osteoarthritis Pain Drugs Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 13. Production Capacity and Capacity Utilization Rate of Major Osteoarthritis Pain Drugs Manufacturers in 2024
Table 14. Manufacturers’ Manufacturing Sites, Areas Served
Table 15. Manufacturers’ Product Type
Table 16. Global Osteoarthritis Pain Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Market Overview of Key Raw Materials
Table 19. Midstream Market Lists
Table 20. Downstream Customer Analysis
Table 21. Key Development Trends
Table 22. Driving Factors
Table 23. Osteoarthritis Pain Drugs Market Challenges
Table 24. World Bank's Forecast Real GDP Growth Rate for 2024-2028
Table 25. Goldman Sachs' Forecast Real GDP Growth Rate for 2025-2026
Table 26. IMF's Forecast Real GDP Growth Rate For 2024-2026
Table 27. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 28. Global Osteoarthritis Pain Drugs Sales by Type (K MT)
Table 29. Global Osteoarthritis Pain Drugs Market Size by Type (M USD)
Table 30. Global Osteoarthritis Pain Drugs Sales (K MT) by Type (2020-2025)
Table 31. Global Osteoarthritis Pain Drugs Sales Market Share by Type (2020-2025)
Table 32. Global Osteoarthritis Pain Drugs Market Size (M USD) by Type (2020-2025)
Table 33. Global Osteoarthritis Pain Drugs Market Share by Type (2020-2025)
Table 34. Global Osteoarthritis Pain Drugs Price (USD/KG) by Type (2020-2025)
Table 35. Global Osteoarthritis Pain Drugs Sales (K MT) by Application
Table 36. Global Osteoarthritis Pain Drugs Market Size by Application
Table 37. Global Osteoarthritis Pain Drugs Sales by Application (2020-2025) & (K MT)
Table 38. Global Osteoarthritis Pain Drugs Sales Market Share by Application (2020-2025)
Table 39. Global Osteoarthritis Pain Drugs Market Size by Application (2020-2025) & (M USD)
Table 40. Global Osteoarthritis Pain Drugs Market Share by Application (2020-2025)
Table 41. Global Osteoarthritis Pain Drugs Sales Growth Rate by Application (2020-2025)
Table 42. Global Osteoarthritis Pain Drugs Sales by Region (2020-2025) & (K MT)
Table 43. Global Osteoarthritis Pain Drugs Sales Market Share by Region (2020-2025)
Table 44. Global Osteoarthritis Pain Drugs Market Size by Region (2020-2025) & (M USD)
Table 45. Global Osteoarthritis Pain Drugs Market Size by Region (2020-2025)
Table 46. North America Osteoarthritis Pain Drugs Sales by Country (2020-2025) & (K MT)
Table 47. North America Osteoarthritis Pain Drugs Market Size by Country (2020-2025) & (M USD)
Table 48. Europe Osteoarthritis Pain Drugs Sales by Country (2020-2025) & (K MT)
Table 49. Europe Osteoarthritis Pain Drugs Market Size by Country (2020-2025) & (M USD)
Table 50. Asia Pacific Osteoarthritis Pain Drugs Sales by Region (2020-2025) & (K MT)
Table 51. Asia Pacific Osteoarthritis Pain Drugs Market Size by Region (2020-2025) & (M USD)
Table 52. South America Osteoarthritis Pain Drugs Sales by Country (2020-2025) & (K MT)
Table 53. South America Osteoarthritis Pain Drugs Market Size by Country (2020-2025) & (M USD)
Table 54. Middle East and Africa Osteoarthritis Pain Drugs Sales by Region (2020-2025) & (K MT)
Table 55. Middle East and Africa Osteoarthritis Pain Drugs Market Size by Region (2020-2025) & (M USD)
Table 56. Global Osteoarthritis Pain Drugs Production (K MT) by Region(2020-2025)
Table 57. Global Osteoarthritis Pain Drugs Revenue (US$ Million) by Region (2020-2025)
Table 58. Global Osteoarthritis Pain Drugs Revenue Market Share by Region (2020-2025)
Table 59. Global Osteoarthritis Pain Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. North America Osteoarthritis Pain Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Europe Osteoarthritis Pain Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Japan Osteoarthritis Pain Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 63. China Osteoarthritis Pain Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Pfizer Basic Information
Table 65. Pfizer Osteoarthritis Pain Drugs Product Overview
Table 66. Pfizer Osteoarthritis Pain Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 67. Pfizer Business Overview
Table 68. Pfizer SWOT Analysis
Table 69. Pfizer Recent Developments
Table 70. Bayer Basic Information
Table 71. Bayer Osteoarthritis Pain Drugs Product Overview
Table 72. Bayer Osteoarthritis Pain Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 73. Bayer Business Overview
Table 74. Bayer SWOT Analysis
Table 75. Bayer Recent Developments
Table 76. SK Chemicals Basic Information
Table 77. SK Chemicals Osteoarthritis Pain Drugs Product Overview
Table 78. SK Chemicals Osteoarthritis Pain Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 79. SK Chemicals Business Overview
Table 80. SK Chemicals SWOT Analysis
Table 81. SK Chemicals Recent Developments
Table 82. GSK Basic Information
Table 83. GSK Osteoarthritis Pain Drugs Product Overview
Table 84. GSK Osteoarthritis Pain Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 85. GSK Business Overview
Table 86. GSK Recent Developments
Table 87. Sanofi Basic Information
Table 88. Sanofi Osteoarthritis Pain Drugs Product Overview
Table 89. Sanofi Osteoarthritis Pain Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 90. Sanofi Business Overview
Table 91. Sanofi Recent Developments
Table 92. Crystal Genomics Basic Information
Table 93. Crystal Genomics Osteoarthritis Pain Drugs Product Overview
Table 94. Crystal Genomics Osteoarthritis Pain Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 95. Crystal Genomics Business Overview
Table 96. Crystal Genomics Recent Developments
Table 97. Johnson and Johnson Basic Information
Table 98. Johnson and Johnson Osteoarthritis Pain Drugs Product Overview
Table 99. Johnson and Johnson Osteoarthritis Pain Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 100. Johnson and Johnson Business Overview
Table 101. Johnson and Johnson Recent Developments
Table 102. Sino Biopharmaceutical Basic Information
Table 103. Sino Biopharmaceutical Osteoarthritis Pain Drugs Product Overview
Table 104. Sino Biopharmaceutical Osteoarthritis Pain Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 105. Sino Biopharmaceutical Business Overview
Table 106. Sino Biopharmaceutical Recent Developments
Table 107. Haohai Biological Basic Information
Table 108. Haohai Biological Osteoarthritis Pain Drugs Product Overview
Table 109. Haohai Biological Osteoarthritis Pain Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 110. Haohai Biological Business Overview
Table 111. Haohai Biological Recent Developments
Table 112. Zhejiang Chengyi Pharmaceutical Basic Information
Table 113. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product Overview
Table 114. Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 115. Zhejiang Chengyi Pharmaceutical Business Overview
Table 116. Zhejiang Chengyi Pharmaceutical Recent Developments
Table 117. Freda Basic Information
Table 118. Freda Osteoarthritis Pain Drugs Product Overview
Table 119. Freda Osteoarthritis Pain Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 120. Freda Business Overview
Table 121. Freda Recent Developments
Table 122. Bright Future Basic Information
Table 123. Bright Future Osteoarthritis Pain Drugs Product Overview
Table 124. Bright Future Osteoarthritis Pain Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 125. Bright Future Business Overview
Table 126. Bright Future Recent Developments
Table 127. Jingfeng Pharmaceutical Basic Information
Table 128. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Product Overview
Table 129. Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 130. Jingfeng Pharmaceutical Business Overview
Table 131. Jingfeng Pharmaceutical Recent Developments
Table 132. Chugai Pharmaceutical Basic Information
Table 133. Chugai Pharmaceutical Osteoarthritis Pain Drugs Product Overview
Table 134. Chugai Pharmaceutical Osteoarthritis Pain Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 135. Chugai Pharmaceutical Business Overview
Table 136. Chugai Pharmaceutical Recent Developments
Table 137. Mikasa Seiyaku Basic Information
Table 138. Mikasa Seiyaku Osteoarthritis Pain Drugs Product Overview
Table 139. Mikasa Seiyaku Osteoarthritis Pain Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 140. Mikasa Seiyaku Business Overview
Table 141. Mikasa Seiyaku Recent Developments
Table 142. Taisho Pharmaceutical Basic Information
Table 143. Taisho Pharmaceutical Osteoarthritis Pain Drugs Product Overview
Table 144. Taisho Pharmaceutical Osteoarthritis Pain Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 145. Taisho Pharmaceutical Business Overview
Table 146. Taisho Pharmaceutical Recent Developments
Table 147. Seikagaku Corporation Basic Information
Table 148. Seikagaku Corporation Osteoarthritis Pain Drugs Product Overview
Table 149. Seikagaku Corporation Osteoarthritis Pain Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 150. Seikagaku Corporation Business Overview
Table 151. Seikagaku Corporation Recent Developments
Table 152. GlaxoSmithKline Basic Information
Table 153. GlaxoSmithKline Osteoarthritis Pain Drugs Product Overview
Table 154. GlaxoSmithKline Osteoarthritis Pain Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 155. GlaxoSmithKline Business Overview
Table 156. GlaxoSmithKline Recent Developments
Table 157. Eli Lilly Basic Information
Table 158. Eli Lilly Osteoarthritis Pain Drugs Product Overview
Table 159. Eli Lilly Osteoarthritis Pain Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 160. Eli Lilly Business Overview
Table 161. Eli Lilly Recent Developments
Table 162. Novartis Basic Information
Table 163. Novartis Osteoarthritis Pain Drugs Product Overview
Table 164. Novartis Osteoarthritis Pain Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 165. Novartis Business Overview
Table 166. Novartis Recent Developments
Table 167. Horizon Pharma Basic Information
Table 168. Horizon Pharma Osteoarthritis Pain Drugs Product Overview
Table 169. Horizon Pharma Osteoarthritis Pain Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 170. Horizon Pharma Business Overview
Table 171. Horizon Pharma Recent Developments
Table 172. Abbott Basic Information
Table 173. Abbott Osteoarthritis Pain Drugs Product Overview
Table 174. Abbott Osteoarthritis Pain Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 175. Abbott Business Overview
Table 176. Abbott Recent Developments
Table 177. Mylan Basic Information
Table 178. Mylan Osteoarthritis Pain Drugs Product Overview
Table 179. Mylan Osteoarthritis Pain Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 180. Mylan Business Overview
Table 181. Mylan Recent Developments
Table 182. Daiichi Sankyo Basic Information
Table 183. Daiichi Sankyo Osteoarthritis Pain Drugs Product Overview
Table 184. Daiichi Sankyo Osteoarthritis Pain Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 185. Daiichi Sankyo Business Overview
Table 186. Daiichi Sankyo Recent Developments
Table 187. TEVA Basic Information
Table 188. TEVA Osteoarthritis Pain Drugs Product Overview
Table 189. TEVA Osteoarthritis Pain Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 190. TEVA Business Overview
Table 191. TEVA Recent Developments
Table 192. Almatica Pharma Basic Information
Table 193. Almatica Pharma Osteoarthritis Pain Drugs Product Overview
Table 194. Almatica Pharma Osteoarthritis Pain Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 195. Almatica Pharma Business Overview
Table 196. Almatica Pharma Recent Developments
Table 197. Astellas Pharma Basic Information
Table 198. Astellas Pharma Osteoarthritis Pain Drugs Product Overview
Table 199. Astellas Pharma Osteoarthritis Pain Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 200. Astellas Pharma Business Overview
Table 201. Astellas Pharma Recent Developments
Table 202. Tide Pharmaceutical Basic Information
Table 203. Tide Pharmaceutical Osteoarthritis Pain Drugs Product Overview
Table 204. Tide Pharmaceutical Osteoarthritis Pain Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 205. Tide Pharmaceutical Business Overview
Table 206. Tide Pharmaceutical Recent Developments
Table 207. Iroko Pharmaceuticals Basic Information
Table 208. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product Overview
Table 209. Iroko Pharmaceuticals Osteoarthritis Pain Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 210. Iroko Pharmaceuticals Business Overview
Table 211. Iroko Pharmaceuticals Recent Developments
Table 212. Hengrui Pharmaceutical Basic Information
Table 213. Hengrui Pharmaceutical Osteoarthritis Pain Drugs Product Overview
Table 214. Hengrui Pharmaceutical Osteoarthritis Pain Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 215. Hengrui Pharmaceutical Business Overview
Table 216. Hengrui Pharmaceutical Recent Developments
Table 217. Global Osteoarthritis Pain Drugs Sales Forecast by Region (2026-2035) & (K MT)
Table 218. Global Osteoarthritis Pain Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 219. North America Osteoarthritis Pain Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 220. North America Osteoarthritis Pain Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 221. Europe Osteoarthritis Pain Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 222. Europe Osteoarthritis Pain Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 223. Asia Pacific Osteoarthritis Pain Drugs Sales Forecast by Region (2026-2035) & (K MT)
Table 224. Asia Pacific Osteoarthritis Pain Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 225. South America Osteoarthritis Pain Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 226. South America Osteoarthritis Pain Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 227. Middle East and Africa Osteoarthritis Pain Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 228. Middle East and Africa Osteoarthritis Pain Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 229. Global Osteoarthritis Pain Drugs Sales Forecast by Type (2026-2035) & (K MT)
Table 230. Global Osteoarthritis Pain Drugs Market Size Forecast by Type (2026-2035) & (M USD)
Table 231. Global Osteoarthritis Pain Drugs Price Forecast by Type (2026-2035) & (USD/KG)
Table 232. Global Osteoarthritis Pain Drugs Sales (K MT) Forecast by Application (2026-2035)
Table 233. Global Osteoarthritis Pain Drugs Market Size Forecast by Application (2026-2035) & (M USD)
List of Figures
Figure 1. Product Picture of Osteoarthritis Pain Drugs
Figure 2. Global Osteoarthritis Pain Drugs Market Size (M USD) (2020-2035)
Figure 3. Global Osteoarthritis Pain Drugs Sales (K MT) & (2020-2035)
Figure 4. Global Osteoarthritis Pain Drugs Market: Capacity and Utilization Outlook (2020-2035)
Figure 5. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 7. Evaluation Matrix of Regional Market Development Potential
Figure 8. Company Assessment Quadrant
Figure 9. Global Osteoarthritis Pain Drugs Product Life Cycle
Figure 10. Osteoarthritis Pain Drugs Sales Share by Manufacturers in 2025
Figure 11. Global Osteoarthritis Pain Drugs Revenue Share by Manufacturers in 2025
Figure 12. Osteoarthritis Pain Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 13. Global Market Osteoarthritis Pain Drugs Average Price (USD/KG) of Key Manufacturers in 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Osteoarthritis Pain Drugs Revenue in 2025
Figure 15. Industry Chain Map of Osteoarthritis Pain Drugs
Figure 16. Osteoarthritis Pain Drugs Market Share of Key Raw Materials (2025)
Figure 17. Key Driving Factors - Impact Assessment
Figure 18. Market Challenges - Severity vs. Frequency Matrix
Figure 19. Key Industry News Timeline
Figure 20. Global Osteoarthritis Pain Drugs Market PEST Analysis
Figure 21. Global Osteoarthritis Pain Drugs Market Porter's Five Forces Analysis
Figure 22. Global Merchandise Trade as a Percentage Of GDP
Figure 23. US - lmports of Goods by Country
Figure 24. China Exports by Country
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Osteoarthritis Pain Drugs Market Share by Type
Figure 27. Sales Market Share of Osteoarthritis Pain Drugs by Type (2020-2025)
Figure 28. Sales Market Share of Osteoarthritis Pain Drugs by Type in 2025
Figure 29. Market Share of Osteoarthritis Pain Drugs by Type (2020-2025)
Figure 30. Market Share of Osteoarthritis Pain Drugs by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Osteoarthritis Pain Drugs Market Share by Application
Figure 33. Global Osteoarthritis Pain Drugs Sales Market Share by Application (2020-2025)
Figure 34. Global Osteoarthritis Pain Drugs Sales Market Share by Application in 2025
Figure 35. Global Osteoarthritis Pain Drugs Market Share by Application (2020-2025)
Figure 36. Global Osteoarthritis Pain Drugs Market Share by Application in 2025
Figure 37. Global Osteoarthritis Pain Drugs Sales Growth Rate by Application (2020-2025)
Figure 38. Global Osteoarthritis Pain Drugs Sales Market Share by Region (2020-2025)
Figure 39. Global Osteoarthritis Pain Drugs Market Size by Region (2020-2025)
Figure 40. North America Osteoarthritis Pain Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Osteoarthritis Pain Drugs Sales Market Share by Country in 2024
Figure 42. North America Osteoarthritis Pain Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. North America Osteoarthritis Pain Drugs Market Size by Country in 2024
Figure 44. U.S. Osteoarthritis Pain Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 45. U.S. Osteoarthritis Pain Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Canada Osteoarthritis Pain Drugs Sales (K MT) and Growth Rate (2020-2025)
Figure 47. Canada Osteoarthritis Pain Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 48. Mexico Osteoarthritis Pain Drugs Sales (K MT) and Growth Rate (2020-2025)
Figure 49. Mexico Osteoarthritis Pain Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 50. Europe Osteoarthritis Pain Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 51. Europe Osteoarthritis Pain Drugs Sales Market Share by Country in 2024
Figure 52. Europe Osteoarthritis Pain Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 53. Europe Osteoarthritis Pain Drugs Market Size by Country in 2024
Figure 54. Germany Osteoarthritis Pain Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 55. Germany Osteoarthritis Pain Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. France Osteoarthritis Pain Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 57. France Osteoarthritis Pain Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. U.K. Osteoarthritis Pain Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 59. U.K. Osteoarthritis Pain Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Italy Osteoarthritis Pain Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 61. Italy Osteoarthritis Pain Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 62. Spain Osteoarthritis Pain Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 63. Spain Osteoarthritis Pain Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 64. Asia Pacific Osteoarthritis Pain Drugs Sales and Growth Rate (K MT)
Figure 65. Asia Pacific Osteoarthritis Pain Drugs Sales Market Share by Region in 2024
Figure 66. Asia Pacific Osteoarthritis Pain Drugs Market Size by Region in 2024
Figure 67. China Osteoarthritis Pain Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. China Osteoarthritis Pain Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Japan Osteoarthritis Pain Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Japan Osteoarthritis Pain Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. South Korea Osteoarthritis Pain Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 72. South Korea Osteoarthritis Pain Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 73. India Osteoarthritis Pain Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 74. India Osteoarthritis Pain Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 75. Southeast Asia Osteoarthritis Pain Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 76. Southeast Asia Osteoarthritis Pain Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 77. South America Osteoarthritis Pain Drugs Sales and Growth Rate (K MT)
Figure 78. South America Osteoarthritis Pain Drugs Sales Market Share by Country in 2024
Figure 79. South America Osteoarthritis Pain Drugs Market Size and Growth Rate (M USD)
Figure 80. South America Osteoarthritis Pain Drugs Market Size by Country in 2024
Figure 81. Brazil Osteoarthritis Pain Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 82. Brazil Osteoarthritis Pain Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 83. Argentina Osteoarthritis Pain Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 84. Argentina Osteoarthritis Pain Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 85. Columbia Osteoarthritis Pain Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 86. Columbia Osteoarthritis Pain Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 87. Middle East and Africa Osteoarthritis Pain Drugs Sales and Growth Rate (K MT)
Figure 88. Middle East and Africa Osteoarthritis Pain Drugs Sales Market Share by Region in 2024
Figure 89. Middle East and Africa Osteoarthritis Pain Drugs Market Size and Growth Rate (M USD)
Figure 90. Middle East and Africa Osteoarthritis Pain Drugs Market Size by Region in 2024
Figure 91. Saudi Arabia Osteoarthritis Pain Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 92. Saudi Arabia Osteoarthritis Pain Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 93. UAE Osteoarthritis Pain Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 94. UAE Osteoarthritis Pain Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 95. Egypt Osteoarthritis Pain Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 96. Egypt Osteoarthritis Pain Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 97. Nigeria Osteoarthritis Pain Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 98. Nigeria Osteoarthritis Pain Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 99. South Africa Osteoarthritis Pain Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 100. South Africa Osteoarthritis Pain Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 101. Global Osteoarthritis Pain Drugs Production Market Share by Region (2020-2025)
Figure 102. North America Osteoarthritis Pain Drugs Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Osteoarthritis Pain Drugs Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Osteoarthritis Pain Drugs Production (K MT) Growth Rate (2020-2025)
Figure 105. China Osteoarthritis Pain Drugs Production (K MT) Growth Rate (2020-2025)
Figure 106. Global Osteoarthritis Pain Drugs Sales Forecast by Volume (2020-2035) & (K MT)
Figure 107. Global Osteoarthritis Pain Drugs Market Size Forecast by Value (2020-2035) & (M USD)
Figure 108. Global Osteoarthritis Pain Drugs Sales Market Share Forecast by Type (2026-2035)
Figure 109. Global Osteoarthritis Pain Drugs Market Share Forecast by Type (2026-2035)
Figure 110. Global Osteoarthritis Pain Drugs Sales Forecast by Application (2026-2035)
Figure 111. Global Osteoarthritis Pain Drugs Market Share Forecast by Application (2026-2035)